Phase II study of 131 I-metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP.
Pediatr Blood Cancer
; 70(11): e30615, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37574821
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Topotecan
/
Neuroblastoma
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
Language:
En
Journal:
Pediatr Blood Cancer
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: